Overview of Dr. Wallbillich
Dr. John Wallbillich is an obstetrician/gynecologist in Detroit, MI and is affiliated with Karmanos Cancer Center. He received his medical degree from University of Michigan Medical School and has been in practice 8 years. He is one of 23 doctors at Karmanos Cancer Center who specialize in Obstetrics & Gynecology.
Education & Training Medical College of Georgia Post-Doctoral Fellowship, NIH Women’s Reproductive Health Research Scholar, 2016 - 2019 Ohio State University College of Medicine Fellowship, Gynecologic Oncology, 2013 - 2016 University of Texas Health Science Center - Houston Residency, Obstetrics and Gynecology, 2009 - 2013 University of Michigan Medical School Class of 2009 Certifications & Licensure MI State Medical License 2019 - 2022 GA State Medical License 2016 - 2019 OH State Medical License 2013 - 2017 American Board of Obstetrics and Gynecology Obstetrics & Gynecology Awards, Honors, & Recognition GCC Superhero Award Georgia Cancer Center at Augusta University, 2019 Felix Rutlege Fellowship MD Anderson Cancer Center, 2012 James B. Angell Scholar University of Michigan, 2004 Join now to see all Publications & Presentations PubMed 1 citations
Comparing mutation frequencies for homologous recombination genes in uterine serous and high-grade serous ovarian carcinomas: A case for homologous recombination defic...
John J. Wallbillich, Robert T. Morris, Rouba Ali-Fehmi> ;Gynecologic Oncology. 2020 Nov 1 1 citations
Changes in microRNA expression associated with metastasis and survival in patients with uveal melanoma.
Ayushi Vashishtha, Tae Jin Lee, Ashok Sharma, John J. Wallbillich> ;Oncotarget. 2020 Apr 21
A 73-gene proliferative transcriptomic signature predicts uterine serous carcinoma patient survival and response to primary therapy.
Lynn Tran, Paul M.H. Tran, David P. Mysona, Sharad Purohit, Emily Myers, Won Sok Lee, Boying Dun, Duo Xu, Haitao Liu, Diane Hopkins, John Nechtman, Chris L. Scelsi, Pa...> ;Gynecologic Oncology. 2020 May 1 Join now to see all Journal Articles Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide (VPCBAE) in the management of three patients with small-cell carcinoma of the ovary John J. Wallbillich, Alpa M. Nick, Pedro T. Ramirez, Jack L. Watkins, Elizabeth D. Euscher, Kathleen M. Schmeler, Gynecologic Oncology Case Reports Abstracts/Posters Clinical Practice Guidelines decrease unnecessary Pap tests in survivors of gynecologic malignancies. Meyer L, Schmeler K, Wallbillich J, Urbauer D, Soliman P, Frumovitz M, Burke C, Bodurka D, Levenback C, The Society for Gynecologic Oncology Annual Meeting on Women’s Cancer; Orlando, FL., 3/1/2011 Clinical Practice Guidelines decrease unnecessary
Pap tests in survivors of gynecologic malignancies. Meyer L, Schmeler K, Wallbillich J, Urbauer D, Soliman P, Frumovitz M, Burke C, Bodurka D, Levenback C, Gynecologic Oncology, 1/1/2011 The Proper Pap: Reducing the Overutilization of Pap Test for Disease Surveillance in Survivors of Gynecologic Malignancies. Meyer L, Levenback C, Wallbillich J, Garcia E, Urbauer D, Soliman P, Frumovitz M, Burke C, Schmeler K, University of Texas System Clinical Safety and Effectiveness Conference; Austin, TX., 11/1/2010 Join now to see all